Watch CBS News

How anticipated COVID-19 vaccines are bulk manufactured under Operation Warp Speed

With $628 million from the U.S. government, Emergent Bio-Solutions in Baltimore is scaling up separate Johnson & Johnson and AstraZeneca COVID-19 vaccines, which are still pending FDA approval.
View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.